MRE11 promotes oral cancer progression through RUNX2/CXCR4/AKT/FOXA2 signaling in a nuclease-independent manner.
Wang YY, Chen YK, Lo S, Chi TC, Chen YH, Hu SC, Chen YW, Jiang SS, Tsai FY, Liu W, Li RN, Hsieh YC, Huang CJ, Yuan SF.
Wang YY, et al. Among authors: chen yw, chen yh, chen yk.
Oncogene. 2021 May;40(20):3510-3532. doi: 10.1038/s41388-021-01698-5. Epub 2021 Apr 29.
Oncogene. 2021.
PMID: 33927349
Free PMC article.